Skip to main content
OpenTrials
Completed

NCT Number: NCT05122832

Prevalence of NCD Risk Factors in Kazakhstan

This is a cross-sectional study that aims to study the prevalence of risk factors of noncommunicable diseases in people aged 18 to 69 years using the standardized and adopted STEPS questionnaire in the Republic of Kazakhstan.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Non-Communicable Chronic Diseases Disease Attributes Noncommunicable Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–69 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kazakhstan

Almaty, 050020, Kazakhstan

About this study

The WHO STEPwise Approach to NCD Risk Factor Surveillance (STEPS) is a simple, standardized method for collecting, analysing and disseminating data on key NCD risk factors in countries. The survey instrument covers key behavioral risk factors: tobacco use, alcohol consumption, physical activity, unhealthy diet, as well as key biological risk factors: overweight and obesity, raised blood pressure, raised blood glucose, and abnormal blood lipids.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age Limits 18-69 years

Treatment and study plan

Blood test

Diagnostic Test

Glucose Glycosylated hemoglobin Triglycerides Total cholesterol HDL Cholesterol LDL Cholesterol Creatinine COVID-19 Antibody IgM to N protein SARS-Cov-2 (Abbott) COVID-19 Antibody IgG to N protein SARS-Cov-2 (Abbott)

STEPwise Approach to NCD Risk Factor Surveillance (STEPS)

Diagnostic Test

The WHO STEPwise Approach to NCD Risk Factor Surveillance (STEPS) is a simple, standardized method for collecting, analysing and disseminating data on key NCD risk factors in countries. The survey instrument covers key behavioral risk factors: tobacco use, alcohol consumption, physical activity, unhealthy diet, as well as key biological risk factors: overweight and obesity, raised blood pressure, raised blood glucose, and abnormal blood lipids. Through the use of expanded modules, the survey instrument can be expanded to cover a range of topics beyond these risk factors, such as oral health, sexual health and road safety.

Spirometry

Diagnostic Test

Spirometry is a common office test used to assess how well your lungs work by measuring how much air you inhale, how much you exhale and how quickly you exhale.

Primary outcomes

  1. tobacco use

    Time frame: 1 year

    currently smoke tobacco, currently smoke tobacco daily, age started smoking, daily smokers smoking manufactured cigarettes

  2. alcohol consumption

    Time frame: 1 year

    lifetime abstainers, past 12 month abstainers, currently drink (drank alcohol in the past 30 days), heavy episodic drinking (6 or more drinks on any occasion in the past 30 days).

  3. physical activity

    Time frame: 1 year

    insufficient physical activity (defined as < 150 minutes of moderate-intensity activity per week, or equivalent), physical activity on average per day (minutes), not engaging in vigorous activity.

  4. unhealthy diet

    Time frame: 1 year

    days fruit consumed in a typical week, servings of fruit consumed on average per day, days vegetables consumed in a typical week, servings of vegetables consumed on average per day, less than 5 servings of fruit and/or vegetables on average per day, always or often add salt or salty sauce to their food before eating or as they are eating, always or often eat processed foods high in salt.

  5. BMI

    Time frame: 1 year

    overweight (BMI ≥ 25 kg/m2), obese (BMI ≥ 30 kg/m2), normal weight

  6. raised blood pressure

    Time frame: 1 year

    systolic blood pressure - SBP (mmHg), including those currently on medication for raised BP, diastolic blood pressure - DBP (mmHg), including those currently on medication for raised BP, raised BP (SBP ≥ 140 and/or DBP ≥ 90 mmHg or currently on medication for raised BP), raised BP (SBP ≥ 140 and/or DBP ≥ 90 mmHg or currently on medication for raised BP) who are not currently on medication for raised BP.

  7. raised blood glucose

    Time frame: 1 year

    fasting blood glucose, including those currently on medication for raised blood glucose, impaired fasting glycaemia (plasma venous value ≥6.1 mmol/L (110 mg/dl) and <7.0 mmol/L (126 mg/dl)), raised fasting blood glucose (plasma venous value ≥ 7.0 mmol/L (126 mg/dl)) or currently on medication for raised blood glucose.

  8. abnormal blood lipids

    Time frame: 1 year

    total blood cholesterol, including those currently on medication for raised cholesterol, raised total cholesterol,

Sponsors and collaborators

Lead sponsor

Asfendiyarov Kazakh National Medical University

Other

Registry information

Official study title

Preventive and Personalized Medicine (2021-2023)

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Nov 17, 2021
Registry last updated
Mar 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.